Trial Profile

Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis AECB

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Levofloxacin (Primary) ; Prulifloxacin (Primary)
Indications Acute exacerbations of chronic bronchitis; Bacterial infections
Focus Therapeutic Use
Sponsors Angelini Group

Most Recent Events

21 Apr 2012 Planned number of patients changed from 284 to 300 as reported by European Clinical Trials Database record.
29 Jun 2011 New trial record
12 Nov 2010 Status changed from recruiting to completed as reported by EudraCT.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com